Literature DB >> 17192469

Peroxisome proliferator-activated receptor-gamma regulates expression of PDX-1 and NKX6.1 in INS-1 cells.

Jacob A Moibi1, Dhananjay Gupta, Thomas L Jetton, Mina Peshavaria, Ronak Desai, Jack L Leahy.   

Abstract

In the 60% pancreatectomy (Px) rat model of beta-cell adaptation, normoglycemia is maintained by an initial week of beta-cell hyperplasia that ceases and is followed by enhanced beta-cell function. It is unknown how this complex series of events is regulated. We studied isolated islets and pancreas sections from 14-day post-Px versus sham-operated rats and observed a doubling of beta-cell nuclear peroxisome proliferator-activated receptor (PPAR)-gamma protein, along with a 2-fold increase in nuclear pancreatic duodenal homeobox (Pdx)-1 protein and a 1.4-fold increase in beta-cell nuclear Nkx6.1 immunostaining. As PPAR-gamma activation is known to both lower proliferation and have prodifferentiation effects in many tissues, we studied PPAR-gamma actions in INS-1 cells. A 3-day incubation with the PPAR-gamma agonist troglitazone reduced proliferation and increased Pdx-1 and Nkx6.1 immunostaining, along with glucokinase and GLUT2. Also, a 75% knockdown of PPAR-gamma using RNA interference lowered the mRNA levels of Pdx-1, glucokinase, GLUT2, and proinsulin II by more than half. Our results show a dual effect of PPAR-gamma in INS-1 cells: to curtail proliferation and promote maturation, the latter via enhanced expression of Pdx-1 and Nkx6.1. Additional studies are needed to determine whether there is a regulatory role for PPAR-gamma signaling in the beta-cell adaptation following a 60% Px in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17192469     DOI: 10.2337/db06-0948

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  27 in total

1.  The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus.

Authors:  D Gupta; T Kono; C Evans-Molina
Journal:  Diabetes Obes Metab       Date:  2010-12       Impact factor: 6.577

2.  Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2.

Authors:  Jianguo Lin; Anping Chen
Journal:  Mol Cell Endocrinol       Date:  2010-12-30       Impact factor: 4.102

Review 3.  Leucine metabolism in regulation of insulin secretion from pancreatic beta cells.

Authors:  Jichun Yang; Yujing Chi; Brant R Burkhardt; Youfei Guan; Bryan A Wolf
Journal:  Nutr Rev       Date:  2010-05       Impact factor: 7.110

4.  AMPK enhances the expression of pancreatic duodenal homeobox-1 via PPARalpha, but not PPARgamma, in rat insulinoma cell line INS-1.

Authors:  Hua Guo; Shui Sun; Xu Zhang; Xiu-juan Zhang; Ling Gao; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

5.  Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets.

Authors:  Hannah J Welters; Abdelfattah El Ouaamari; Dan Kawamori; John Meyer; Jiang Hu; David M Smith; Rohit N Kulkarni
Journal:  Endocrinology       Date:  2012-07-17       Impact factor: 4.736

6.  Heterozygous deletion of Seipin in islet beta cells of male mice has an impact on insulin synthesis and secretion through reduced PPARγ expression.

Authors:  Jianwei Xiong; Peng Sun; Ya Wang; Xu Hua; Wenyu Song; Yan Wang; Jie Wu; Wenfeng Yu; George Liu; Ling Chen
Journal:  Diabetologia       Date:  2019-11-27       Impact factor: 10.122

7.  Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure.

Authors:  Carmella Evans-Molina; Reiesha D Robbins; Tatsuyoshi Kono; Sarah A Tersey; George L Vestermark; Craig S Nunemaker; James C Garmey; Tye G Deering; Susanna R Keller; Bernhard Maier; Raghavendra G Mirmira
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

8.  Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: possible mechanism for the GIP resistance in type 2 diabetes.

Authors:  Dhananjay Gupta; Mina Peshavaria; Navjot Monga; Thomas L Jetton; Jack L Leahy
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

Review 9.  Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  2010-04-02       Impact factor: 10.122

Review 10.  Thiazolidinediones in prediabetes and early type 2 diabetes: what can be learned about that disease's pathogenesis.

Authors:  Jack L Leahy
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.